Interestingly, this study also found that TP53 mutations were significantly correlated with the increased expression of PHLDA1 and PHLDA3 in PAAD, and the high expression of PHLDA1/3 was associated with poor prognosis in patients with PAAD. The gene discussed is TP53; the disease is pancreatic adenocarcinoma.